1.
Classification of Recombinant Biologics in the EU: Divergence between National Pharmacovigilance Centers
2.
3.
Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports